Published in Clin Infect Dis on June 21, 2002
Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis (2010) 2.69
Viral encephalitis in England, 1989-1998: what did we miss? Emerg Infect Dis (2003) 2.26
Validation of laboratory screening criteria for herpes simplex virus testing of cerebrospinal fluid. J Clin Microbiol (2007) 1.28
Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J Neuroimmunol (2009) 1.16
Etiology of encephalitis in Australia, 1990-2007. Emerg Infect Dis (2009) 1.14
Novel human reovirus isolated from children with acute necrotizing encephalopathy. Emerg Infect Dis (2011) 1.14
DNA probe array for the simultaneous identification of herpesviruses, enteroviruses, and flaviviruses. J Clin Microbiol (2005) 1.08
The incidence of acute encephalitis syndrome in Western industrialised and tropical countries. Virol J (2008) 1.08
Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis (2009) 1.07
Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia. J Neuroinflammation (2011) 1.05
Infection-associated encephalopathies: their investigation, diagnosis, and treatment. J Neurol (2006) 1.03
New estimates of incidence of encephalitis in England. Emerg Infect Dis (2013) 0.96
Neuro-intensive care of patients with acute CNS infections. Neurotherapeutics (2012) 0.94
Initial and long-term costs of patients hospitalized with West Nile virus disease. Am J Trop Med Hyg (2014) 0.94
Aetiologies of central nervous system infections in adults in Kathmandu, Nepal: a prospective hospital-based study. Sci Rep (2013) 0.92
Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010. PLoS One (2014) 0.90
Underreporting of viral encephalitis and viral meningitis, Ireland, 2005-2008. Emerg Infect Dis (2013) 0.89
Trends in encephalitis-associated deaths in the United States. Epidemiol Infect (2006) 0.87
Acute encephalitis hospitalizations, California, 1990-1999: unrecognized arboviral encephalitis? Emerg Infect Dis (2004) 0.85
Herpes Simplex Encephalitis: An Uncommon Presentation. J Clin Diagn Res (2016) 0.84
Herpes encephalitis presenting as mild aphasia: case report. BMC Fam Pract (2006) 0.83
Potential clinical impact of the film array meningitis encephalitis panel in children with suspected central nervous system infections. Diagn Microbiol Infect Dis (2016) 0.82
2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (2012) 0.81
Use of staged molecular analysis to determine causes of unexplained central nervous system infections. Emerg Infect Dis (2013) 0.80
Should there be a standardised approach to the diagnostic workup of suspected adult encephalitis? A case series from Australia. BMC Infect Dis (2010) 0.80
Incidence Rate of Acute Encephalitis Syndrome without Specific Treatment in India and Nepal. Indian J Community Med (2012) 0.78
Encephalitis, Ontario, Canada, 2002-2013. Emerg Infect Dis (2016) 0.78
Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management. Neurotherapeutics (2016) 0.77
Effect of combinations of antiviral drugs on herpes simplex encephalitis. Drug Des Devel Ther (2009) 0.77
Encephalitis Surveillance through the Emerging Infections Program, 1997-2010. Emerg Infect Dis (2015) 0.77
Infectious causes of encephalitis and meningoencephalitis in Thailand, 2003-2005. Emerg Infect Dis (2015) 0.77
Review: apoptotic mechanisms in bacterial infections of the central nervous system. Front Immunol (2012) 0.76
Economic burden of West Nile virus in the United States. Am J Trop Med Hyg (2014) 0.76
Rehabilitation interventions in children and adults with infectious encephalitis: a systematic review protocol. BMJ Open (2016) 0.75
Encephalitis-associated hospitalizations among American Indians and Alaska Natives. Am J Trop Med Hyg (2014) 0.75
Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy. Epilepsia (2017) 0.75
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27
Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis (2002) 6.09
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA (2005) 5.84
Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis (2002) 5.64
Human metapneumovirus infections in young and elderly adults. J Infect Dis (2003) 4.91
Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep (2004) 3.84
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35
Rhinovirus-associated hospitalizations in young children. J Infect Dis (2007) 3.35
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A (2004) 3.23
The relationship between in-home water service and the risk of respiratory tract, skin, and gastrointestinal tract infections among rural Alaska natives. Am J Public Health (2008) 3.09
In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis (2003) 2.99
Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis. J Virol (2009) 2.96
Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis (2004) 2.88
Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol (2006) 2.67
Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis (2007) 2.65
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep (2003) 2.53
Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis (2012) 2.48
Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis (2004) 2.35
Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol (2010) 2.29
Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Clin Infect Dis (2008) 2.27
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J (2012) 2.12
Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses. J Clin Microbiol (2008) 2.10
Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. Children. Pediatr Infect Dis J (2005) 2.07
Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol (2011) 2.07
Detection of novel SARS-like and other coronaviruses in bats from Kenya. Emerg Infect Dis (2009) 2.04
Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J (2012) 2.03
Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg (2010) 1.99
Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains. Virus Res (2003) 1.96
Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis (2011) 1.93
Infectious disease hospitalizations among infants in the United States. Pediatrics (2008) 1.90
Novel human rhinoviruses and exacerbation of asthma in children. Emerg Infect Dis (2008) 1.87
Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics (2004) 1.83
GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness. J Clin Microbiol (2003) 1.83
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol (2008) 1.80
Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis (2009) 1.78
Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000. Emerg Infect Dis (2002) 1.78
Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis (2006) 1.71
Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J (2003) 1.71
Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. Am J Trop Med Hyg (2005) 1.69
Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis (2008) 1.68
Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis (2004) 1.65
Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics (2006) 1.64
Kawasaki syndrome hospitalizations among children in the United States, 1988-1997. Pediatrics (2003) 1.62
Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology (2014) 1.47
Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J (2006) 1.46
Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. J Immunol (2006) 1.45
Sequence polymorphism of the predicted human metapneumovirus G glycoprotein. J Gen Virol (2004) 1.44
Infectious disease hospitalizations in the United States. Clin Infect Dis (2009) 1.43
Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J (2006) 1.35
Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J (2003) 1.35
Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J (2011) 1.34
Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus. J Am Geriatr Soc (2006) 1.32
Variation in timing of respiratory syncytial virus outbreaks: lessons from national surveillance. Pediatr Infect Dis J (2007) 1.30
Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis (2006) 1.30
Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog (2008) 1.27
Kawasaki syndrome in Denmark. Pediatr Infect Dis J (2007) 1.24
Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice. J Virol (2009) 1.23
Infectious disease hospitalizations among American Indian and Alaska native infants. Pediatrics (2003) 1.23
Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice. J Infect Dis (2009) 1.22
Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus. Clin Diagn Lab Immunol (2002) 1.22
Evaluation of smallpox vaccines using variola neutralization. J Gen Virol (2009) 1.21
Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol (2013) 1.20
The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. J Virol (2003) 1.20
Infection control practices and zoonotic disease risks among veterinarians in the United States. J Am Vet Med Assoc (2008) 1.18
Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J (2003) 1.15
Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch Intern Med (2005) 1.15
Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients. J Immunol (2009) 1.14
Viral meningitis-associated hospitalizations in the United States, 1988-1999. Neuroepidemiology (2003) 1.13
National surveillance and the epidemiology of human Q fever in the United States, 1978-2004. Am J Trop Med Hyg (2006) 1.12
Trends in lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general US child population. J Pediatr (2012) 1.12
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J (2008) 1.09
Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology (2005) 1.08
Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis. Pediatrics (2010) 1.08
Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J (2009) 1.08
Rocky Mountain spotted fever in the United States, 1997-2002. Vector Borne Zoonotic Dis (2006) 1.08
Outbreak of pneumonia associated with emergent human adenovirus serotype 14--Southeast Alaska, 2008. J Infect Dis (2010) 1.08
Methicillin-resistant Staphylococcus aureus-associated hospitalizations among the American Indian and Alaska native population. Clin Infect Dis (2009) 1.07
Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice. J Gen Virol (2009) 1.07
Knowledge of bat rabies and human exposure among United States cavers. Emerg Infect Dis (2002) 1.07
Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerg Infect Dis (2007) 1.05
Severe acute respiratory syndrome: review and lessons of the 2003 outbreak. Int J Epidemiol (2004) 1.04
Refractory status epilepticus in suspect encephalitis. Neurocrit Care (2008) 1.04
SARS surveillance during emergency public health response, United States, March-July 2003. Emerg Infect Dis (2004) 1.03
Fatal Rocky Mountain spotted fever in the United States, 1999-2007. Am J Trop Med Hyg (2012) 1.03
Epidemiology of cat-scratch disease hospitalizations among children in the United States. Pediatr Infect Dis J (2005) 1.02
Investigation of Kawasaki syndrome risk factors in Colorado. Pediatr Infect Dis J (2002) 1.02
Assessing the magnitude of fatal Rocky Mountain spotted fever in the United States: comparison of two national data sources. Am J Trop Med Hyg (2002) 1.02
Temporal and geographic trends of rotavirus activity in the United States, 1997-2004. Pediatr Infect Dis J (2006) 1.00
Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii. Pediatr Infect Dis J (2007) 0.99